|
Re: Bioasis Corporate Presentation Slide Deck from March 2019
|
1
|
BIOASIS TECHNOLOGIES INC
|
Apr 09, 2019 10:25AM
|
|
Re: Apabetalone......a Calculated Risk
|
5
|
Resverlogix Corp.
|
Apr 09, 2019 08:59AM
|
|
Re: Apabetalone......a Calculated Risk
|
6
|
Resverlogix Corp.
|
Apr 09, 2019 08:34AM
|
|
Re: Gonna check back for the last 15 mintues....
|
1
|
Resverlogix Corp.
|
Apr 08, 2019 04:55PM
|
|
Bioasis Corporate Presentation Slide Deck from March 2019
|
1
|
BIOASIS TECHNOLOGIES INC
|
Apr 08, 2019 12:12PM
|
|
Re: AACR
|
8
|
Zenith Epigenetics
|
Apr 08, 2019 11:46AM
|
|
NCT03901469: A Study of ZEN003694 and Talazoparib in Patients With Triple Negative Breast Cancer (TNBC)
|
6
|
Zenith Epigenetics
|
Apr 08, 2019 07:40AM
|
|
Re: fully adjudicated?
|
2
|
Resverlogix Corp.
|
Apr 07, 2019 09:01PM
|
|
Re: fully adjudicated?
|
7
|
Resverlogix Corp.
|
Apr 07, 2019 08:42PM
|
|
Re: Apabetalone......a Calculated Risk
|
7
|
Resverlogix Corp.
|
Apr 07, 2019 07:16AM
|
|
Re: What's nice about April
|
4
|
Resverlogix Corp.
|
Apr 05, 2019 10:16AM
|
|
Zacks SCR 4/2/2019: BETonMACE Final Event Expected April 2019
|
1
|
Resverlogix Corp.
|
Apr 02, 2019 04:29PM
|
|
The Faces of Cardiovascular Disease: Part 3
|
2
|
Resverlogix Corp.
|
Apr 02, 2019 02:37PM
|
|
Re: 2019 Potential Events
|
3
|
Resverlogix Corp.
|
Apr 02, 2019 01:50PM
|
|
Re: Can we expect for 5 point MACE to be near our phase 2 trials results
|
2
|
Resverlogix Corp.
|
Apr 02, 2019 01:08PM
|
|
Re: The Phase 1 trail CKD in New Zealand
|
3
|
Resverlogix Corp.
|
Apr 02, 2019 12:55PM
|
|
Re: News article on epigenetics
|
4
|
Resverlogix Corp.
|
Apr 02, 2019 09:00AM
|
|
Re: RBC unregistered to registered account
|
5
|
Zenith Epigenetics
|
Apr 01, 2019 09:25PM
|
|
Re: RBC unregistered to registered account
|
3
|
Zenith Epigenetics
|
Apr 01, 2019 08:11PM
|
|
Re: AACR
|
3
|
Zenith Epigenetics
|
Apr 01, 2019 05:58PM
|
